A potential COVID-19 vaccine, the first to be developed in India, has been given DCGI (Drug Controller General of India) approval for Phase I and II human clinical trials that are scheduled to start across the country in July. Developed by Hyderabad-based Bharat Biotech, in association with ICMR (Indian Council for Medical Research), COVAXIN is an inactivated vaccine, created from a strain of the infectious SARS-CoV-2 virus, that has shown promise in preclinical studies, demonstrating extensive safety and effective immune responses.
from Videos https://ift.tt/2Ag1JNP
Subscribe to:
Post Comments (Atom)
-
By Unknown Author from NYT Podcasts https://ift.tt/3B1FtRR
-
"Swipe to see how Masaba forgot the dress-code and tried to make her dress white because she got shouted at but ending up looking like ...
No comments:
Post a Comment